Type 2 Diabetes Trial, Recruiting NCT05662462 Sponsor: Ohio State University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05662462
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are pregnant and aged 18 or older
  • People who are 20 weeks pregnant or less (specifically, less than 20 weeks and 6 days)
  • People who had Type 2 diabetes before becoming pregnant, with a blood sugar control result (called an A1c) of 6.5% or higher at the time of joining the study
  • People who have Medicaid insurance
  • People who speak English or Spanish
  • People who are mentally able to complete all the study tasks
  • People who agree to take part in all study activities
  • People who are available and able to participate in study activities throughout the trial
  • People who own and use a smartphone with internet access
  • People who agree to let the study team access their electronic health records, use a continuous glucose monitor (a small device that tracks blood sugar) if placed in the intervention group, have their clinic, hospital, and emergency room visits tracked, and have their use of a health app called ACHIEVE tracked (including which features they use, such as recording blood sugar, booking appointments, messaging healthcare providers, or accessing educational materials)

Who may not be able to join:

  • No specific exclusion criteria were listed in the official trial information (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Naleef Fareed, PhD, MBA, Ohio State University

Phone: 614-293-2222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University
Registry
ClinicalTrials.gov
Start date
11 July 2024
Est. completion
1 May 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The primary clinical outcome is the proportion of participants with an A1c <6.5% in the third trimester before delivery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov